Loading...
Sulfasalazine — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Sulfasalazine
2025-Q4
Comprehensive analysis of India’s sulfasalazine export trade — suppliers, buyers, prices, routes, and every shipment record.
39
Shipments
$174K
Trade Value
18
Suppliers
17
Buyers
16
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/sulfasalazine
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s sulfasalazine trade — 2025-Q4
KEY TAKEAWAY
Sulfasalazine 2025-Q4 exports total $173.5K across 16 countries, with THE MADRAS PHARMACEUTICALS commanding 43.6% market share.
TOTAL SHIPMENTS
39
2025-Q4
EXPORT VALUE
$173.5K
FOB USD
TOTAL QUANTITY
1.1M
units shipped
INDIAN SUPPLIERS
18
unique exporters
GLOBAL BUYERS
17
unique importers
DESTINATIONS
16
countries
MEDIAN UNIT PRICE
$0.544
per unit
TOP-5 SHARE
96.1%
of total USD
BRANDED SHARE
66.7%
26 shipments
DOSAGE FORMS
2
product types
6 KEY FINDINGS
1
THE MADRAS PHARMACEUTICALS is India's #1 Sulfasalazine exporter with $75.7K (43.6% market share).→ §5, Indian Supplier Rankings
2
Sulfasalazine reached 16 countries, with Sri Lanka as the top destination ($92.8K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 2728) — top 10 suppliers control 99.6% of exports.→ §5, Indian Supplier Rankings
4
88.2% of buyers (15 of 17) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (90.3%) across 2 dosage forms.→ §7, Price Benchmarks
6
16 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 THE MADRAS PHARMACEUTICALS leads in volume — how do 18 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian sulfasalazine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Sulfasalazine report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial sulfasalazine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian sulfasalazine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Sulfasalazine India trade report
Product scope
Sulfasalazine
All variants merged — branded and generic formulations of sulfasalazine
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
39
Every commercial sulfasalazine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $68.0K, Nov $85.7K, Dec $19.9K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$68.0K
Oct USD
4 shipments
2
$85.7K
Nov USD
+26.1% MoM
3
$19.9K
Dec USD
-76.8% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 26.1% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $68K, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $174K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $18K rise in Nov, $66K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $68K | 4 shipments |
| Nov | $86K | 17 shipments |
| Dec | $20K | 18 shipments |
| Q4 Total | $174K | 39 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Sri Lanka held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: 3S CORP maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import sulfasalazine from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Sri Lanka absorbs 53.5% of India’s 2025-Q4 sulfasalazine trade ($92.8K). Beyond the top 10 destinations, 16 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 7 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 16 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much sulfasalazine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$102K
58.8% of trade
5 countries · 18 shipments
Americas
$65K
37.7% of trade
4 countries · 11 shipments
Africa
$6K
3.5% of trade
7 countries · 10 shipments
Fig 4.1 Sri Lanka is the #1 corridor ($93K) — 16 flow arcs from India radiate across 3 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian sulfasalazine it receives (light = low, dark = high). Orange arcs radiate from India to the top 16 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Sri Lanka | $93K | 7 | THE MADRAS PHARMACEUTICALS | $76K | WALLACE PHARMACEUTICALS PVT LTD | $17K | — | — |
| 2 | Peru | $33K | 2 | KWALITY PHARMACEUTICALS LTD | $33K | — | — | — | — |
| 3 | Canada | $31K | 1 | STERIL-GENE LIFE SCIENCES PVT LTD | $31K | — | — | — | — |
| 4 | Jordan | $9K | 1 | ZYMETH PHARMACEUTICALS PVT LTD | $9K | — | — | — | — |
| 5 | Liberia | $4K | 1 | NAPO EXPORTS PVT LTD | $4K | — | — | — | — |
| 6 | Tanzania | $1K | 3 | BARAKAH BIOHEALTH LLP | $1K | — | — | — | — |
| 7 | Chile | $729 | 2 | WALLACE PHARMACEUTICALS PVT LTD | $729 | — | — | — | — |
| 8 | Kenya | $566 | 2 | 3S CORP | $566 | — | — | — | — |
| 9 | Guyana | $450 | 6 | PEAK HEALTHCARE | $273 | NAMAN GLOBAL IMPEX PVT LTD | $141 | AVANCE HEALTHCARE PVT LTD | $36 |
| 10 | Somalia | $365 | 1 | WORLDPRIME EXPORT LLP | $365 | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 58.8% of USD — but Sri Lanka is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
53.5%
#1 country share
Sri Lanka alone
97.8%
Top 5 share
5 of 16 countries
100.0%
Top 15 share
Long tail of 1 countries = 0.0%
HHI 3580
Destination HHI
Highly concentrated
16
Countries served
Global pharma reach from India
7
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
18 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
THE MADRAS PHARMACEUTICALS ($75.7K, 43.6% share) and KWALITY PHARMACEUTICALS LTD ($33.1K) together control 62.7% of India’s 2025-Q4 sulfasalazine trade. The top 5 suppliers hold 96.1%. 18 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian sulfasalazine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 THE MADRAS PHARMACEUTICALS leads by $43K over KWALITY PHARMACEUTICALS LTD — top 18 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: DERRIC WOOD is #14 by value but #1 by volume.
Fig 5.2 DERRIC WOOD also leads by shipment count (6) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: DERRIC WOOD moves from #1 by volume to #14 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 18 sulfasalazine suppliers split into strategic segments
KEY TAKEAWAY
5 suppliers (25%) generate 96.1% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 THE MADRAS PHARMACEUTICALS and KWALITY PHARMACEUTICALS LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 96.1% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | WALLACE PHARMACEUTICALS PVT LTD | 2 | 2 | $18K |
| 2 | THE MADRAS PHARMACEUTICALS | 1 | 1 | $76K |
| 3 | KWALITY PHARMACEUTICALS LTD | 1 | 1 | $33K |
| 4 | STERIL-GENE LIFE SCIENCES PVT LTD | 1 | 1 | $31K |
| 5 | ZYMETH PHARMACEUTICALS PVT LTD | 1 | 1 | $9K |
| 6 | NAPO EXPORTS PVT LTD | 1 | 1 | $4K |
| 7 | BARAKAH BIOHEALTH LLP | 1 | 1 | $1K |
| 8 | 3S CORP | 1 | 1 | $566 |
| 9 | WORLDPRIME EXPORT LLP | 1 | 1 | $365 |
| 10 | PEAK HEALTHCARE | 1 | 1 | $273 |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the sulfasalazine manufacturing hubs
KEY TAKEAWAY
Chennai and Karapakkam together account for $76K of India’s 2025-Q4 sulfasalazine trade.
Fig 5.5 Chennai (2 exporters, $38K) and Karapakkam (1 exporters, $38K) are India’s sulfasalazine capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
96.1%
Top 5 share
5 of 18 suppliers
99.6%
Top 10 share
10 of 18 suppliers
96.1%
Top 25% share
5 suppliers = 96% USD
HHI 2728
Supplier HHI
Concentrated
18
Total suppliers
shipped Sulfasalazine in 2025-Q4
15+ cities
Indian hubs
Chennai and Karapakkam lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | WALLACE PHARMACEUTICALS PVT LTD | $18K |
#4
EXPORTER PROFILE #1 OF 1
WALLACE PHARMACEUTICALS PVT LTD
Panjim · India’s #4 sulfasalazine supplier by USD · 2025-Q4
2025-Q4 USD
$18K
10.3% market share
SHIPMENTS
5
avg $4K/ship
COUNTRIES
2
destination markets
BUYERS
2
2 single-sourced
BRANDED
60%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
Sri Lanka is the #1 market at $17K (96% of trade), followed by Chile at $729. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Sri Lanka | $17K | 3 | 95.9% |
| 2 | Chile | $729 | 2 | 4.1% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $18K.
PRODUCT MIX
delayed tablet dominates at 94% of trade. Tablet (5.9%) and others are secondary formulations.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| EMAR PHARMA (PVT) LTD | Sri Lanka | $17K | ⚠ Locked |
| PHARMAMERICA LTDA | Chile | $729 | ⚠ Locked |
#4
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
WALLACE PHARMACEUTICALS PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 Sri Lanka absorbs $17K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
17 importers across 16 countries — who is buying Indian sulfasalazine and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 15 importers together hold only 77.1% of total USD. 88% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian sulfasalazine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 M/S.PHARMA ASSOCIATES is the #1 importer at $38K (21.8%) — top 15 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 15 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
88%
Single-source
15 buyers rely on exactly 1 Indian supplier
6%
Dual-source
1 buyers use 2 Indian suppliers
6%
Multi-source (3–4)
1 buyers diversified across 3–4
0%
Broad-source (5+)
0 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source sulfasalazine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Sri Lanka 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| M/S.PHARMA ASSOCIATES | THE MADRAS PHARMACEU… | $38K | $2.988 | Tablet |
| EMAR PHARMA (PVT) LTD | WALLACE PHARMACEUTIC… | $17K | $1.500 | delayed tablet |
Kenya 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| FOR THE ORDER OF | 3S CORP | $497.742 | $49.774 | Tablet |
| FOR THE .ORDER OF | 3S CORP | $67.891 | $6.789 | Tablet |
Peru 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| AXIERTA CAL. EMETE RIO… | KWALITY PHARMACEUTIC… | $33K | $0.033 | Tablet |
Canada 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| JAMP PHARMA CORPORATON | STERIL-GENE LIFE SCI… | $31K | $24.921 | Tablet |
Jordan 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BALSAM DRUG STORE | ZYMETH PHARMACEUTICA… | $9K | $2.422 | Tablet |
§6.3 Price positioning — top 15 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | M/S.PHARMA ASSOCIATES | Sri Lanka | $38K | $19K | Mid |
| 2 | AXIERTA CAL. EMETE R… | Peru | $33K | $17K | Mid |
| 3 | JAMP PHARMA CORPORATON | Canada | $31K | $31K | Mid |
| 4 | EMAR PHARMA (PVT) LTD | Sri Lanka | $17K | $6K | Budget |
| 5 | BALSAM DRUG STORE | Jordan | $9K | $9K | Budget |
| 6 | ABEER PHARMACEUTICALS | Liberia | $4K | $4K | Budget |
| 7 | PHARMAMERICA LTDA | Chile | $729.093 | $365.000 | Budget |
| 8 | FOR THE ORDER OF | Kenya | $497.742 | $498.000 | Budget |
| 9 | SUCCESS INTER LINK P… | Singapore | $225.457 | $75.000 | Budget |
| 10 | FREIGHTER MADE LOGIS… | Ghana | $194.779 | $195.000 | Budget |
| 11 | FOR THE .ORDER OF | Kenya | $67.891 | $68.000 | Budget |
| 12 | EMIRATES POST COMPANY | United Arab Emirates | $58.432 | $10.000 | Budget |
| 13 | LUSAKA PHARMA CHEM S… | Zambia | $13.162 | $13.000 | Budget |
| 14 | STATE TRADING ORGANI… | Maldives | $8.929 | $9.000 | Budget |
| 15 | GOOD HEALTH (PTY) LTD | Seychelles | $1.503 | $2.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 18 × 15 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 THE MADRAS PHARMACEUTICALS → M/S.PHARMA ASSOCIATES is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 18 Indian suppliers; right = top 15 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian sulfasalazine prices vary by supplier, country and dosage form
KEY TAKEAWAY
Sulfasalazine prices span 2191970× ($0.0000 → $49.77). The coefficient of variation is 2.63. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0000 | Lowest observed unit price |
| P5 | $0.0082 | 5th percentile |
| P25 | $0.047 | 25th percentile (Q1) |
| Median | $0.544 | 50th percentile (Q2) |
| P75 | $3.72 | 75th percentile (Q3) |
| P95 | $10.42 | 95th percentile |
| Max | $49.77 | Highest observed unit price |
| Mean | $3.35 | Arithmetic average |
| CV | 263% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 3S CORP prices at $28.28/unit vs market median $0.544.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. KWALITY PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. THE MADRAS PHARMACEUTICALS Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. NAPO EXPORTS PVT Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. STERIL-GENE LIFE SCIENCES Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | 3S CORP | Kenya | Tablet | 10 | $497.74 | $49.77 | Specialty / small-batch |
| Oct 2025 | STERIL-GENE LIFE… | Canada | Tablet | 1K | $31K | $24.92 | Specialty / small-batch |
| Dec 2025 | 3S CORP | Kenya | Tablet | 10 | $67.89 | $6.79 | Specialty / small-batch |
| Dec 2025 | WORLDPRIME EXPOR… | Somalia | Tablet | 70 | $365.32 | $5.22 | Specialty / small-batch |
| Nov 2025 | SANITAS MEDTECH … | Singapore | Tablet | 38 | $186.41 | $4.91 | Specialty / small-batch |
| Nov 2025 | SANITAS MEDTECH … | Singapore | Tablet | 5 | $24.41 | $4.88 | Specialty / small-batch |
| Nov 2025 | SANITAS MEDTECH … | Singapore | Tablet | 3 | $14.64 | $4.88 | Specialty / small-batch |
| Dec 2025 | WALLACE PHARMACE… | Sri Lanka | delayed tablet | 4K | $17K | $4.17 | Specialty / small-batch |
| Nov 2025 | THE MADRAS PHARM… | Sri Lanka | Tablet | 10K | $37K | $3.72 | Specialty / small-batch |
| Nov 2025 | THE MADRAS PHARM… | Sri Lanka | Tablet | 10K | $37K | $3.72 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | AL-SUPREME EXPORTS | Seychelles | Tablet | 200 | $1.50 | $0.0075 | Bulk generic tablet |
| Dec 2025 | BARAKAH BIOHEALT… | Tanzania | Tablet | 2K | $12.59 | $0.0084 | Bulk generic tablet |
| Dec 2025 | WALLACE PHARMACE… | Chile | Tablet | 12K | $365.02 | $0.031 | |
| Dec 2025 | WALLACE PHARMACE… | Chile | Tablet | 12K | $364.07 | $0.031 | |
| Oct 2025 | KWALITY PHARMACE… | Peru | Tablet | 500K | $17K | $0.033 | |
| Oct 2025 | KWALITY PHARMACE… | Peru | Tablet | 500K | $17K | $0.033 | |
| Dec 2025 | AVANCE HEALTHCAR… | Guyana | Tablet | 750 | $27.08 | $0.036 | Small sample / trial shipment |
| Dec 2025 | AVANCE HEALTHCAR… | Guyana | — | 250 | $9.03 | $0.036 | Small sample / trial shipment |
| Dec 2025 | WALLACE PHARMACE… | Sri Lanka | Tablet | 7K | $318.87 | $0.047 | |
| Nov 2025 | MC PHARMA DISTRI… | Maldives | Tablet | 180 | $8.93 | $0.050 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship sulfasalazine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Sulfasalazine leaves India through 8+ ports. The top 5 (CHENNAI SEA, TUGHLAKABAD ICD, BANGALORE AIR) handle 96.8% of total USD. SEA moves 28% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 CHENNAI SEA handles $76K — top 8 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Colombo is the #1 global destination port — top 19 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 28% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$80K
46.2% of USD · 28.2% of ships
AIR
$60K
34.8% of USD · 66.7% of ships
ICD
$33K
19.1% of USD · 5.1% of ships
Fig 8.3 The dominant corridor is CHENNAI SEA → Sea → Asia ($76K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
United Arab Emirates is the most concentrated destination (HHI 10000, 1 suppliers). Guyana is the most competitive (HHI 4721).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 United Arab Emirates (HHI 10,000) is the most concentrated — Guyana (HHI 4,721) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 16 of 16 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| M/S.PHARMA ASSOCIATES | Sri Lanka | THE MADRAS PHARM… | $38K | 2 | MEDIUM |
| AXIERTA CAL. EMETE R… | Peru | KWALITY PHARMACE… | $33K | 2 | MEDIUM |
| JAMP PHARMA CORPORATON | Canada | STERIL-GENE LIFE… | $31K | 1 | MEDIUM |
| EMAR PHARMA (PVT) LTD | Sri Lanka | WALLACE PHARMACE… | $17K | 3 | MEDIUM |
| BALSAM DRUG STORE | Jordan | ZYMETH PHARMACEU… | $9K | 1 | MEDIUM |
| ABEER PHARMACEUTICALS | Liberia | NAPO EXPORTS PVT… | $4K | 1 | MEDIUM |
| PHARMAMERICA LTDA | Chile | WALLACE PHARMACE… | $729 | 2 | MEDIUM |
| FOR THE ORDER OF | Kenya | 3S CORP | $498 | 1 | MEDIUM |
Conclusion: 15 buyers depend on exactly one Indian supplier, representing $134K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Peru | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Canada | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Jordan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Liberia | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Tanzania | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Chile | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Guyana | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Somalia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Singapore | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Ghana | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Zambia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Maldives | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Sri Lanka | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit United Arab Emirates lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Sri Lanka (2 suppliers) | This Q | HIGH |
| A6 | Enter Peru (1 suppliers) | This Q | MED |
| A8 | Build Peru distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Sri Lanka tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Sri Lanka | Asia | 2 | $93K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Peru | Other | 1 | $33K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Canada | Other | 1 | $31K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Jordan | Other | 1 | $9K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Liberia | Africa | 1 | $4K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Tanzania | Africa | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Chile | Other | 1 | $729 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Kenya | Africa | 1 | $566 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Guyana | Other | 3 | $450 | 0% | LOW | Low competition (3 suppliers), accessible market |
| 10 | Somalia | Africa | 1 | $365 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Singapore | Asia | 1 | $225 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Ghana | Africa | 1 | $195 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | United Arab Emirates | Other | 1 | $58 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Zambia | Africa | 1 | $13 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Maldives | Asia | 1 | $9 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 39 2025-Q4 Sulfasalazine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/sulfasalazine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 39 2025-Q4 sulfasalazine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian sulfasalazine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
39
across all regions
TOTAL USD
$174K
2025-Q4 FOB value
UNITS
1.1M
tablets, capsules, etc.
SUPPLIERS
18
Indian exporters
BUYERS
17
global importers
COUNTRIES
16
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $6K (3.5%), spanning 7 countries.
18 Indian suppliers shipped to 17 buyers across 16 countries — average shipment value $4K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
7 countries · 10 shipments · $6K · 7 Indian suppliers · 7 buyers
SHIPMENTS
10
USD
$6K
COUNTRIES
7
SUPPLIERS
7
BUYERS
7
HHI
4,333
concentrated
Top 7 destination countries in Africa
1
Liberia (61.9%)
$4K
2
Tanzania (19.0%)
$1K
3
Kenya (9.4%)
$565.63
4
Somalia (6.1%)
$365.32
5
Ghana (3.3%)
$194.78
6
Zambia (0.2%)
$13.16
7
Seychelles (0.0%)
$1.50
Top 7 Indian suppliers into Africa
1
NAPO EXPORTS PVT LTD
$4K
2
BARAKAH BIOHEALTH LLP
$1K
3
3S CORP
$565.63
4
WORLDPRIME EXPORT LLP
$365.32
5
BAKER & DAVIS PVT LTD
$194.78
6
MEDICOS LIFESCIENCES
$13.16
7
AL-SUPREME EXPORTS
$1.50
Top 6 Africa importers
1
ABEER PHARMACEUTICALS · Liberia
$4K
2
FOR THE ORDER OF · Kenya
$497.74
3
FREIGHTER MADE LOGISTICS LTD · Ghana
$194.78
4
FOR THE .ORDER OF · Kenya
$67.89
5
LUSAKA PHARMA CHEM SUPPLIES LTD · Zambia
$13.16
6
GOOD HEALTH (PTY) LTD · Seychelles
$1.50
Top 1 dosage forms
1
Tablet
$6K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $4K | $4K |
| Nov | 3 | $705.68 | $235.23 |
| Dec | 6 | $2K | $262.58 |
Shipment register · 10 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — NAPO EXPORTS PVT LTD · 1 shipments · $4K | |||||||||||
| 1 | Oct 2025 | ABEER PHARMACEUTICALS | Liberia | Tablet | 6.8K | PCS | $0.544 | $4K | NHAVA SHEVA SEA (JNPT) | Monrovia | SEA |
| SUPPLIER #2 — BARAKAH BIOHEALTH LLP · 3 shipments · $1K | |||||||||||
| 2 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 1.5K | NOS | $0.752 | $1K | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| 3 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 1.5K | NOS | $0.0084 | $12.59 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| 4 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 1.5K | NOS | $0.0000 | $0.0000 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #3 — 3S CORP · 2 shipments · $565.63 | |||||||||||
| 5 | Nov 2025 | FOR THE ORDER OF | Kenya | Tablet | 10 | NOS | $49.77 | $497.74 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 6 | Dec 2025 | FOR THE .ORDER OF | Kenya | Tablet | 10 | NOS | $6.79 | $67.89 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #4 — WORLDPRIME EXPORT LLP · 1 shipments · $365.32 | |||||||||||
| 7 | Dec 2025 | UNLISTED BUYER | Somalia | Tablet | 70 | NOS | $5.22 | $365.32 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #5 — BAKER & DAVIS PVT LTD · 1 shipments · $194.78 | |||||||||||
| 8 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 500 | NOS | $0.390 | $194.78 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #6 — MEDICOS LIFESCIENCES · 1 shipments · $13.16 | |||||||||||
| 9 | Nov 2025 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | Tablet | 50 | NOS | $0.263 | $13.16 | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #7 — AL-SUPREME EXPORTS · 1 shipments · $1.50 | |||||||||||
| 10 | Dec 2025 | GOOD HEALTH (PTY) LTD | Seychelles | Tablet | 200 | NOS | $0.0075 | $1.50 | CHENNAI AIR | MAHE ISLAND | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
5 countries · 18 shipments · $102K · 6 Indian suppliers · 7 buyers
SHIPMENTS
18
USD
$102K
COUNTRIES
5
SUPPLIERS
6
BUYERS
7
HHI
5,859
concentrated
Top 5 destination countries in Asia
1
Sri Lanka (90.9%)
$93K
2
Jordan (8.8%)
$9K
3
Singapore (0.2%)
$225.46
4
United Arab Emirates (0.1%)
$58.43
5
Maldives (0.0%)
$8.93
Top 6 Indian suppliers into Asia
1
THE MADRAS PHARMACEUTICALS
$76K
2
WALLACE PHARMACEUTICALS PVT LTD
$17K
3
ZYMETH PHARMACEUTICALS PVT LTD
$9K
4
SANITAS MEDTECH INSTITUTE PVT LTD
$225.46
5
DERRIC WOOD
$58.43
6
MC PHARMA DISTRIBUTORS
$8.93
Top 6 Asia importers
1
M/S.PHARMA ASSOCIATES · Sri Lanka
$38K
2
EMAR PHARMA (PVT) LTD · Sri Lanka
$17K
3
BALSAM DRUG STORE · Jordan
$9K
4
SUCCESS INTER LINK PTE LTD · Singapore
$225.46
5
EMIRATES POST COMPANY · United Arab Emirates
$58.43
6
STATE TRADING ORGANIZATION PLC · Maldives
$8.93
Top 2 dosage forms
1
Tablet
$85K
2
delayed tablet
$17K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 14 | $85K | $6K |
| Dec | 4 | $17K | $4K |
Shipment register · 18 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — THE MADRAS PHARMACEUTICALS · 4 shipments · $76K | |||||||||||
| 1 | Nov 2025 | M/S.PHARMA ASSOCIATES | Sri Lanka | Tablet | 9.8K | PCS | $3.72 | $37K | CHENNAI SEA | Colombo | SEA |
| 2 | Nov 2025 | M/S.PHARMA ASSOCIATES | Sri Lanka | Tablet | 2.9K | PCS | $0.476 | $1K | CHENNAI SEA | Colombo | SEA |
| 3 | Nov 2025 | UNKNOWN BUYER | Sri Lanka | Tablet | 9.8K | PCS | $3.72 | $37K | CHENNAI SEA | Colombo | SEA |
| 4 | Nov 2025 | UNKNOWN BUYER | Sri Lanka | Tablet | 2.9K | PCS | $0.476 | $1K | CHENNAI SEA | Colombo | SEA |
| SUPPLIER #2 — WALLACE PHARMACEUTICALS PVT LTD · 3 shipments · $17K | |||||||||||
| 5 | Dec 2025 | EMAR PHARMA (PVT) LTD | Sri Lanka | delayed tablet | 4.0K | NOS | $4.17 | $17K | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 6 | Dec 2025 | EMAR PHARMA (PVT) LTD | Sri Lanka | Tablet | 6.7K | NOS | $0.047 | $318.87 | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 7 | Dec 2025 | EMAR PHARMA (PVT) LTD | Sri Lanka | Tablet | 637 | NOS | $0.0000 | $0.014 | MUMBAI AIR (SAHAR) | COLOMBO | SEA |
| SUPPLIER #3 — ZYMETH PHARMACEUTICALS PVT LTD · 1 shipments · $9K | |||||||||||
| 8 | Nov 2025 | BALSAM DRUG STORE | Jordan | Tablet | 3.7K | NOS | $2.42 | $9K | AHMEDABAD AIR | AMMAN | AIR |
| SUPPLIER #4 — SANITAS MEDTECH INSTITUTE PVT LTD · 3 shipments · $225.46 | |||||||||||
| 9 | Nov 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 38 | NOS | $4.91 | $186.41 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 10 | Nov 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 5 | NOS | $4.88 | $24.41 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 11 | Nov 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 3 | NOS | $4.88 | $14.64 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #5 — DERRIC WOOD · 6 shipments · $58.43 | |||||||||||
| 12 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $0.543 | $9.78 | DELHI AIR | DUBAI | AIR |
| 13 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $0.546 | $9.84 | DELHI AIR | DUBAI | AIR |
| 14 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $0.550 | $9.90 | DELHI AIR | DUBAI | AIR |
| 15 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 14 | PCS | $0.854 | $11.96 | DELHI AIR | DUBAI | AIR |
| 16 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 14 | PCS | $0.854 | $11.96 | DELHI AIR | DUBAI | AIR |
| 17 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $0.556 | $5.00 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #6 — MC PHARMA DISTRIBUTORS · 1 shipments · $8.93 | |||||||||||
| 18 | Nov 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Tablet | 180 | PCS | $0.050 | $8.93 | CHENNAI AIR | MALE | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
4 countries · 11 shipments · $65K · 6 Indian suppliers · 5 buyers
SHIPMENTS
11
USD
$65K
COUNTRIES
4
SUPPLIERS
6
BUYERS
5
HHI
4,827
concentrated
Top 4 destination countries in Americas
1
Peru (50.5%)
$33K
2
Canada (47.7%)
$31K
3
Chile (1.1%)
$729.09
4
Guyana (0.7%)
$450.37
Top 6 Indian suppliers into Americas
1
KWALITY PHARMACEUTICALS LTD
$33K
2
STERIL-GENE LIFE SCIENCES PVT LTD
$31K
3
WALLACE PHARMACEUTICALS PVT LTD
$729.09
4
PEAK HEALTHCARE
$272.92
5
NAMAN GLOBAL IMPEX PVT LTD
$141.35
6
AVANCE HEALTHCARE PVT LTD
$36.10
Top 3 Americas importers
1
AXIERTA CAL. EMETE RIO PEREZ · Peru
$33K
2
JAMP PHARMA CORPORATON · Canada
$31K
3
PHARMAMERICA LTDA · Chile
$729.09
Top 2 dosage forms
1
Tablet
$65K
2
Unknown
$9.03
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $64K | $21K |
| Nov | 0 | $0.0000 | — |
| Dec | 8 | $1K | $147.43 |
Shipment register · 11 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — KWALITY PHARMACEUTICALS LTD · 2 shipments · $33K | |||||||||||
| 1 | Oct 2025 | AXIERTA CAL. EMETE RIO PEREZ | Peru | Tablet | 500.0K | NOS | $0.033 | $17K | TUGHLAKABAD ICD | CALLAO | ICD |
| 2 | Oct 2025 | AXIERTA CAL. EMETE RIO PEREZ | Peru | Tablet | 500.0K | NOS | $0.033 | $17K | TUGHLAKABAD ICD | CALLAO | ICD |
| SUPPLIER #2 — STERIL-GENE LIFE SCIENCES PVT LTD · 1 shipments · $31K | |||||||||||
| 3 | Oct 2025 | JAMP PHARMA CORPORATON | Canada | Tablet | 1.3K | NOS | $24.92 | $31K | BANGALORE AIR | MONTREAL, QC | AIR |
| SUPPLIER #3 — WALLACE PHARMACEUTICALS PVT LTD · 2 shipments · $729.09 | |||||||||||
| 4 | Dec 2025 | PHARMAMERICA LTDA | Chile | Tablet | 11.9K | NOS | $0.031 | $365.02 | MUMBAI AIR (SAHAR) | SANTIAGO DE CHILE - | AIR |
| 5 | Dec 2025 | PHARMAMERICA LTDA | Chile | Tablet | 11.8K | NOS | $0.031 | $364.07 | NHAVA SHEVA SEA (JNPT) | Valparaiso | SEA |
| SUPPLIER #4 — PEAK HEALTHCARE · 3 shipments · $272.92 | |||||||||||
| 6 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 300 | NOS | $0.455 | $136.50 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 7 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 300 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 8 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 300 | NOS | $0.455 | $136.42 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #5 — NAMAN GLOBAL IMPEX PVT LTD · 1 shipments · $141.35 | |||||||||||
| 9 | Dec 2025 | UNKNOWN BUYER | Guyana | Tablet | 200 | NOS | $0.707 | $141.35 | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| SUPPLIER #6 — AVANCE HEALTHCARE PVT LTD · 2 shipments · $36.10 | |||||||||||
| 10 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 750 | NOS | $0.036 | $27.08 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 11 | Dec 2025 | UNLISTED BUYER | Guyana | 250 | NOS | $0.036 | $9.03 | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR | |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 18 Indian sulfasalazine exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped sulfasalazine in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | THE MADRAS PHARMACEUTICALS | CHENNAI | 4 | $76K | Tablet | Asia |
| 2 | KWALITY PHARMACEUTICALS LTD | AMRITSAR | 2 | $33K | Tablet | Americas |
| 3 | STERIL-GENE LIFE SCIENCES PVT LTD | VILLIANUR COMMUNE PONDY | 1 | $31K | Tablet | Americas |
| 4 | WALLACE PHARMACEUTICALS PVT LTD | PANJIM | 5 | $18K | delayed tablet, Tablet | Asia, Americas |
| 5 | ZYMETH PHARMACEUTICALS PVT LTD | AHMEDABAD | 1 | $9K | Tablet | Asia |
| 6 | NAPO EXPORTS PVT LTD | Indore | 1 | $4K | Tablet | Africa |
| 7 | BARAKAH BIOHEALTH LLP | Tiruppur | 3 | $1K | Tablet | Africa |
| 8 | 3S CORP | MUMBAI | 2 | $565.63 | Tablet | Africa |
| 9 | WORLDPRIME EXPORT LLP | JUNAGADH | 1 | $365.32 | Tablet | Africa |
| 10 | PEAK HEALTHCARE | MUMBAI | 3 | $272.92 | Tablet | Americas |
| 11 | SANITAS MEDTECH INSTITUTE PVT LTD | Narhen | 3 | $225.46 | Tablet | Asia |
| 12 | BAKER & DAVIS PVT LTD | MUMBAI | 1 | $194.78 | Tablet | Africa |
| 13 | NAMAN GLOBAL IMPEX PVT LTD | MUMBAI | 1 | $141.35 | Tablet | Americas |
| 14 | DERRIC WOOD | SUBHASH PLACE | 6 | $58.43 | Tablet | Asia |
| 15 | AVANCE HEALTHCARE PVT LTD | RAJKOT | 2 | $36.10 | Tablet | Americas |
| 16 | MEDICOS LIFESCIENCES | AHMEDABAD | 1 | $13.16 | Tablet | Africa |
| 17 | MC PHARMA DISTRIBUTORS | CHENNAI | 1 | $8.93 | Tablet | Asia |
| 18 | AL-SUPREME EXPORTS | NAGERCOIL | 1 | $1.50 | Tablet | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 15 global sulfasalazine importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian sulfasalazine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | M/S.PHARMA ASSOCIATES | Sri Lanka | 2 | $38K | THE MADRAS PHARMACEU… | Tablet |
| 2 | AXIERTA CAL. EMETE RIO PEREZ | Peru | 2 | $33K | KWALITY PHARMACEUTIC… | Tablet |
| 3 | JAMP PHARMA CORPORATON | Canada | 1 | $31K | STERIL-GENE LIFE SCI… | Tablet |
| 4 | EMAR PHARMA (PVT) LTD | Sri Lanka | 3 | $17K | WALLACE PHARMACEUTIC… | delayed tablet, Tablet |
| 5 | BALSAM DRUG STORE | Jordan | 1 | $9K | ZYMETH PHARMACEUTICA… | Tablet |
| 6 | ABEER PHARMACEUTICALS | Liberia | 1 | $4K | NAPO EXPORTS PVT LTD | Tablet |
| 7 | PHARMAMERICA LTDA | Chile | 2 | $729.09 | WALLACE PHARMACEUTIC… | Tablet |
| 8 | FOR THE ORDER OF | Kenya | 1 | $497.74 | 3S CORP | Tablet |
| 9 | SUCCESS INTER LINK PTE LTD | Singapore | 3 | $225.46 | SANITAS MEDTECH INST… | Tablet |
| 10 | FREIGHTER MADE LOGISTICS LTD | Ghana | 1 | $194.78 | BAKER & DAVIS PVT LTD | Tablet |
| 11 | FOR THE .ORDER OF | Kenya | 1 | $67.89 | 3S CORP | Tablet |
| 12 | EMIRATES POST COMPANY | United Arab Emirates | 6 | $58.43 | DERRIC WOOD | Tablet |
| 13 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | 1 | $13.16 | MEDICOS LIFESCIENCES | Tablet |
| 14 | STATE TRADING ORGANIZATION PLC | Maldives | 1 | $8.93 | MC PHARMA DISTRIBUTORS | Tablet |
| 15 | GOOD HEALTH (PTY) LTD | Seychelles | 1 | $1.50 | AL-SUPREME EXPORTS | Tablet |
This report covers 39 2025-Q4 Sulfasalazine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/sulfasalazine
Talk to our trade analyst
Need a custom sulfasalazine report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/sulfasalazine
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Sulfasalazine product page
Live data, supplier directory, price trends, and trade route analysis